Oncological Programme of the Czech Republic
Aims:
Lowering of incidence and mortality rates of tumor diseases.
Improvement of quality of life of oncologically ill.
Racionalization of diagnosis and treatment costs of tumor diseases
in the Czech Republic.
Strategy:
- Fight against malignant tumors as part of countrywide and regional political agenda.
- Fight against malignant tumors as the life interest of lay and professional public.
- International co-operation and harmonization in the framework of EU and WHO partnership structures.
- Sustainability of the fight against cancer by cost control.
- Assessment and continuous evaluation of indicators, outputs and outcomes, functioning and effectivity of NOP. Annual commentary on the fulfilment, optionally revision and supplementation.
Tasks:
- Expert support for tumor prevention training at schools.
Popularization of primary tumor prevention with the public.
Lowering of smokers number, primarily among youth and women.
Support for positive changes in lifestyle and nutrition.
- Ensure longterm functioning and auditing of screening
programmes of breast carcinoma, carcinoma of the cervix and
colorectum carcinoma. Simultaneously evaluate the influence of
parascreening investigations in the population.
- Improve early diagnostics of malignant tumors, particularly in
co-operation with practitioners. Inovate preventive checkup content
to integrate the detection of oncological, cardiovascular and
metabolic diseases.
- Name a net of centres of complex diagnostics-treatment of
oncological care, accredited by CSO on the basis of four
competences: qualification, equipmet, self-evaluation and
communication. Create a Council of Oncocentres of the Czech
Republic as a tool for activity coordination.
- Enforcement of equity, that is accessibility of the whole
population to comparable oncological services and prevention
information, diagnostics and treatment of oncological
diseases.
- Ensure the anchoring and stability of processes for palliative
and terminal care. Support development of home care. Observe the
state of quality of life and pain treatment of patients with
advanced malignant tumors.
- Support for continuity, stabilization, modernization and
practical utilisation of National Oncological Register of the Czech
Republuic Database for controlled preventive and
diagnosis-treatment care in oncology.
- Support for applied oncological research and inovation. Introduction of HTA (health technology assessment) in oncology. Support for education in oncology.
On behalf of the Board of the Oncological Society of ČLS
JEP
Prof. MUDr. Jiří Vorlíček, CSc.